Arecor Therapeutics PLC (AREC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.178x

Based on the latest financial reports, Arecor Therapeutics PLC (AREC) has a cash flow conversion efficiency ratio of -0.178x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.15 Million ≈ $-139.56 USD) by net assets (GBX6.45 Million ≈ $785.27 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AREC company net worth for the company's overall valuation and market capitalisation.

Arecor Therapeutics PLC - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Arecor Therapeutics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Arecor Therapeutics PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arecor Therapeutics PLC ranked by their cash flow conversion efficiency. Explore AREC cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
AFFINOR GROWERS INC. F:1AF0	0.027x
Dewata Freight International Tbk PT JK:DEAL	0.041x
Sleep Number Corp NASDAQ:SNBR	0.012x
Hill Street Beverage Company Inc V:HILL	-0.272x
Kendrick Resources PLC LSE:KEN	0.101x
CABASSE S.A. EO -50 F:LB0	N/A
Chelverton UK Dividend Trust PLC LSE:SDV	0.022x
Anexo Group Plc LSE:ANX	-0.057x

Annual Cash Flow Conversion Efficiency for Arecor Therapeutics PLC (2018–2025)

The table below shows the annual cash flow conversion efficiency of Arecor Therapeutics PLC from 2018 to 2025. View Arecor Therapeutics PLC (AREC) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX6.45 Million ≈ $785.27	GBX-2.29 Million ≈ $-278.63	-0.355x	+79.27%
2024-12-31	GBX5.35 Million ≈ $650.82	GBX-9.15 Million ≈ $-1.11K	-1.712x	-179.16%
2023-12-31	GBX9.53 Million ≈ $1.16K	GBX-5.84 Million ≈ $-710.68	-0.613x	+0.73%
2022-12-31	GBX17.45 Million ≈ $2.12K	GBX-10.78 Million ≈ $-1.31K	-0.618x	-110.20%
2021-12-31	GBX18.55 Million ≈ $2.26K	GBX-5.45 Million ≈ $-663.11	-0.294x	+87.75%
2020-12-31	GBX773.79K ≈ $94.15	GBX-1.86 Million ≈ $-225.90	-2.399x	-1577.65%
2019-12-31	GBX3.21 Million ≈ $390.31	GBX-458.80K ≈ $-55.82	-0.143x	+75.93%
2019-05-31	GBX4.22 Million ≈ $512.95	GBX-2.50 Million ≈ $-304.76	-0.594x	+19.14%
2018-05-31	GBX670.33K ≈ $81.56	GBX-492.57K ≈ $-59.93	-0.735x	--

About Arecor Therapeutics PLC

LSE:AREC UK Biotechnology

Market Cap

$401.97K

GBX3.30 Billion GBX

Market Cap Rank

#31139 Global

#956 in UK

Share Price

GBX87.50

Change (1 day)

+0.00%

52-Week Range

GBX57.50 - GBX92.50

All Time High

GBX450.00